These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1827009)

  • 21. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
    Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
    J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isradipine in the treatment of hypertension. Some additional effects observed during a one-year study.
    Mayer O; Polivkova H; Rottenborn J
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):140S-143S. PubMed ID: 1827005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of isradipine in essential hypertension.
    Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
    Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistical evaluation of circadian blood pressure rhythm during isradipine long-term therapy.
    Veglio F; Rabbia F; Melchio R; Chiandussi L
    Eur J Clin Pharmacol; 1994; 46(2):119-22. PubMed ID: 8039529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Farragi D
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
    Ding YA; Han CL; Chou TC; Lai WY; Shiao MF
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S32-7. PubMed ID: 1376832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt and blood pressure responses to calcium antagonism in hypertensive patients.
    Weir MR; Hall PS; Behrens MT; Flack JM
    Hypertension; 1997 Sep; 30(3 Pt 1):422-7. PubMed ID: 9314427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
    Sundstedt CD; Rüegg PC; Keller A; Waite R
    Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of calcium channel blockade on skin blood flow in diabetic hypertension: a comparison of isradipine and atenolol.
    Rendell MS; Shehan MA; Kahler K; Bailey KL; Eckermann AJ
    Angiology; 1997 Mar; 48(3):203-13. PubMed ID: 9071195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
    Cantor A; Cristal N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the 24-hour effect of a once-daily antihypertensive drug on the diurnal blood pressure profile].
    Abetel G; Karly M; Soret P
    Schweiz Med Wochenschr; 1990 Dec; 120(49):1890-3. PubMed ID: 2148223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 Jan; 3(1):8-15. PubMed ID: 2137344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
    Pereira-Miguel JM; Correa-Nunes A; Rocha-Gonçalves F; Mariano-Pego G
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.
    Fetkovská N; Fedelesová V; Kozlovský M; Dzúrik R
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):175S-177S. PubMed ID: 1827014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension.
    Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of isradipine on blood pressure and renal function.
    Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
    Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The calcium antagonist isradipine and its effect on blood pressure related to plasma renin activity.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 May; 3(5 Pt 1):354-9. PubMed ID: 2140943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.